{
    "title": "Prescription for growth at Pfizer? Analysts say deals",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4465688/Pfizer-beats-quarter-profit-estimates.html",
    "date": "2017-05-02",
    "keywords": [
        "percent",
        "treatment",
        "pfizer",
        "drug",
        "cancer",
        "analyst",
        "share",
        "erman",
        "divya",
        "grover",
        "order",
        "prostate",
        "mampa",
        "number",
        "estimate",
        "quarter",
        "company",
        "assistance",
        "york",
        "drugmaker",
        "growth",
        "vaccine",
        "prevnar",
        "breast",
        "ibrance",
        "novartis",
        "kisqali",
        "ability",
        "absence",
        "goldman",
        "sachs",
        "conference",
        "call",
        "read",
        "future",
        "government",
        "tax",
        "healthcare",
        "reform",
        "need",
        "target",
        "makeorbreak",
        "value",
        "environment",
        "market",
        "revenue",
        "selling",
        "year",
        "copycat",
        "pipeline",
        "thinner",
        "side",
        "part",
        "tim",
        "anderson",
        "acquisition",
        "medivation",
        "inc",
        "decline",
        "amount",
        "upside",
        "income",
        "thomson",
        "forecast",
        "afternoon",
        "trading",
        "stock",
        "exchange",
        "reporting",
        "bengaluru",
        "editing",
        "chakrabarty",
        "zieminski"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}